CMAX CareMax, Inc.: Price-to-Projected Revenue Ratio
CareMax, Inc. (CMAX) relies on a skilled staff of medical professionals and coordinators to ensure high-quality elderly care. Business efficiency is based on AI analytics and a value-based care model. However, critical debt and losses create a threat of default. The projected price-to-sales valuation illustrates the price action, where the 0.00 level reflects the current magnitude of this metric.
Comprehensive metric breakdowns and analytics for CareMax, Inc (CMAX)
- current price and projected stock value:
- company stock capitalization data:
- book value of equity indicators:
- debt level and financial liquidity data:
Total Debt to Equity Ratio CareMax, Inc.|CMAX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital CareMax, Inc.|CMAX - Company Total Debt Obligations|Debt to Book Capitalization Ratio CareMax, Inc|CMAX - Company Long-Term Indebtedness|Company Short-Term Debts CareMax|Quick Liquidity Indicator caremax.com
- financial results and valuation multiples details:
CMAX - Net Financial Result|Projected Future Earnings CareMax, Inc.|CMAX - Price to Earnings Ratio|Future Price to Earnings CareMax Medical Group|CMAX - Price/Earnings to Growth Multiple|EV/EBITDA Multiple CareMax, Inc|CMAX - Operating profit EBITDA|Net earnings per share for the last 12 months CareMax|CMAX - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months caremax.com|CMAX - Net earnings per one share growth for the current year|Net earnings per share growth forecast for next year CareMax, Inc.
- total revenue and sales volume data:
Comprehensive company analysis:CMAX (CareMax)
The forward P/S reflects the market value of the business relative to expected sales volumes, allowing for an assessment of the premium investors are willing to pay per unit of future revenue. The trend on the forward P/S chart for CareMax, Inc. (CMAX) reveals the resilience of the model to costs, which is critical given the fixed government payments per patient that provide the issuer with high cash flow predictability for years to come.
Competitor analysis for CareMax, Inc.
Forward P/S Multiple HCA (HCA Healthcare)|Tenet Healthcare Corp (THC) - Market Cap to Future Revenue Ratio|FMS - Price-to-Projected Revenue Ratio|Solventum Health (SOLV) - Forward Price-to-Revenue Multiple|EHC: Forward P/S Multiple|Universal Health Services, Inc. (UHS) - Forward P/S Multiple|Forward Price-to-Revenue Multiple DVA|Market Cap to Projected Revenue RDNT (RadNet Inc)|Forward Price-to-Revenue Multiple OPCH (Option Care Health Inc)|SGRY (Surgery Partners Group) - Forward Price to Sales|Forward P/S Multiple PINC (Premier, Inc.)|Market Cap to Expected Sales Ratio nationalvision.com (EYE)|PGNY - Price-to-Projected Revenue Ratio|ARDT (Ardent Health) - Market Cap to Projected Revenue|SEM: Forward P/S Multiple|Forward Price-to-Revenue Multiple Astrana Corp|Forward Price-to-Revenue Multiple MD|US Physical Therapy Inc (USPH) - Market Cap to Expected Sales Ratio|Forward P/S Multiple PNTG|Forward Price-to-Revenue Multiple Organogenesis Holdings Inc. ORGO|Price-to-Projected Revenue Ratio Nutex Health Corp NUTX|AUNA - Forward Price-to-Revenue Multiple|SBC Medical Corp - Forward P/S Multiple|EOLS - Forward P/S Multiple|CYH (Community Health Systems, Inc.) - Forward Price-to-Revenue Multiple|Market Cap to Projected Revenue SKIN|Forward Price-to-Revenue Multiple MDWD|BTMD (Biote Corporation) - Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio The Joint Corp. (JYNT)|DCGO (docgo.com) - Forward Price to Sales|Forward P/S Multiple PIII (P3 Health Partners)|Gain Therapeutics Inc. (GANX) - Market Cap to Future Revenue Ratio|EUDA Health - Forward P/S Multiple|BMGL - Forward P/S Multiple|CLGN (collplant.com) - Forward Price-to-Revenue Multiple|CUPR: Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio Concord Medical|Forward Price-to-Revenue Multiple American Shared Hospital Services Inc (AMS)|Forward P/S Multiple MRM|ALBT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio DIH Holding US, Inc. DHAI|XAGE: Market Cap to Projected Revenue|NIVF: Forward Price-to-Revenue Multiple|ATI Physical Therapy - Price to Expected Revenue Ratio|KDLY: Forward P/S Multiple|Forward Price-to-Revenue Multiple ModivCare Corp|NVOS (Novo Integrated Sciences) - Forward P/S Multiple|Forward P/S Multiple SunLink Health Systems, Inc|Price-to-Projected Revenue Ratio IMAC Holdings (BACK)
